Promising early-phase trial results for a new disease-modifying therapy in ALS. Hope is tempered by the need for larger confirmatory studies. - https://nuernberg-libersave.de/merchants/herr-dr-med-jurgen-haas-3fc9451128901ea8 , The neuroimaging findings presented here advance our understanding of functional neurological disorders. Stigma reduction is equally important. .